These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12841017)

  • 1. Lipoproteins in acute coronary syndromes--measure, treat or disregard?
    Henkin Y; Goldbourt U; Gottlieb S
    Isr Med Assoc J; 2003 Jun; 5(6):428-33. PubMed ID: 12841017
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary and secondary prevention of coronary heart disease. Evidence offers multiple strategies.
    Lynn MM
    Adv Nurse Pract; 2000 Jun; 8(6):36-41; quiz 42-3. PubMed ID: 15658206
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical inquiries. What is the best strategy for monitoring the lipid-lowering effects of medical therapy used for the primary prevention of coronary artery disease (CAD)?
    Sherrod JP; Krist A
    J Fam Pract; 2001 Nov; 50(11):928. PubMed ID: 11711006
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on statins and other lipid-lowering drugs.
    Miller CA
    Geriatr Nurs; 2001; 22(5):276-7. PubMed ID: 11606910
    [No Abstract]   [Full Text] [Related]  

  • 5. Alternate-day dosing of statins for secondary prevention of coronary artery disease/The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels.
    Celik M; Celik T
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):253; author reply 253-4. PubMed ID: 19520663
    [No Abstract]   [Full Text] [Related]  

  • 6. Statin therapy: not just used to lower cholesterol?
    Kronmann L; Hatfield C; Kronmann K
    Crit Care Nurs Q; 2007; 30(2):154-60. PubMed ID: 17356356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How effective is prevention in coronary heart disease?
    Cupples ME; Smith SM; Murphy AW
    Heart; 2008 Nov; 94(11):1370-1. PubMed ID: 18931151
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetic dyslipidemia: a practical guide to therapy.
    Tovar JM; Bazaldua OV; Loffredo A
    J Fam Pract; 2008 Jun; 57(6):377-88. PubMed ID: 18544321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event?
    Goyal A; Blazing M
    Am Heart J; 2005 Oct; 150(4):650-1. PubMed ID: 16209959
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of JUPITER to the current practice for prevention and therapy of coronary heart disease].
    Zhao SP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):312-3. PubMed ID: 19791465
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of C-reactive protein (CRP) and statin treatment in reducing cardiovascular risk.
    Chin J
    S D Med; 2009 Mar; 62(3):104-6. PubMed ID: 19480274
    [No Abstract]   [Full Text] [Related]  

  • 12. [Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].
    Sudhop T; von Bergmann K
    MMW Fortschr Med; 2003 May; 145(21):19. PubMed ID: 12845862
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical significance of statin pleiotropic effects: hypotheses versus evidence.
    Davidson MH
    Circulation; 2005 May; 111(18):2280-1. PubMed ID: 15883224
    [No Abstract]   [Full Text] [Related]  

  • 14. Are lipid-lowering guidelines evidence-based?
    Abramson J; Wright JM
    Lancet; 2007 Jan; 369(9557):168-9. PubMed ID: 17240267
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug insight: Statin use in the elderly.
    Raffel OC; White HD
    Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):318-28. PubMed ID: 16729010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. By Jove! What is a clinician to make of JUPITER?
    Kaul S; Morrissey RP; Diamond GA
    Arch Intern Med; 2010 Jun; 170(12):1073-7. PubMed ID: 20585074
    [No Abstract]   [Full Text] [Related]  

  • 17. Statins in the prevention of transplant coronary artery disease: in pediatric heart recipients.
    Pahl E
    Pediatr Transplant; 2007 Aug; 11(5):459-60. PubMed ID: 17631010
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary prevention and statins: is it just about going to class?
    Krasuski RA
    Mayo Clin Proc; 2008 Dec; 83(12):1313-5. PubMed ID: 19046549
    [No Abstract]   [Full Text] [Related]  

  • 19. Preventing coronary heart disease and stroke with aggressive statin therapy in older adults using a team management model.
    Mason CM
    J Am Acad Nurse Pract; 2009 Jan; 21(1):47-53. PubMed ID: 19125895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Don't trust an LDL over 70?
    Aronow WS
    Geriatrics; 2004 May; 59(5):12-3. PubMed ID: 15152729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.